SCHEMBL920268

SCHEMBL920268

COc1c(-c2ncncn2)ccc2[nH]c(C(F)F)nc12

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL477289 0.66 ALDH1A1 (0.50) ALDH1A1POLB
SCHEMBL31157033 0.66 ALDH1A1 (0.50) ALDH1A1POLB
SCHEMBL4728823 0.66 KDM4E (0.41)
SCHEMBL20150109 0.63 TSHR (0.38) ALDH1A1POLB
SCHEMBL909787 0.60 CBFB (0.54) ALDH1A1POLB
SCHEMBL28941969 0.58 NQO2 (0.41) ALDH1A1POLB
SCHEMBL174453 0.58 CYP1A2 (0.54) ALDH1A1POLB
SCHEMBL12452478 0.57 ALDH1A1 (0.49) ALDH1A1POLB
SCHEMBL3969749 0.57 ALDH1A1 (0.49) ALDH1A1POLB
SCHEMBL13154906 0.57 ALDH1A1 (0.49) ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2276750-A2 SUBSTITUTED PYRIMIDINES AND TRIAZINES AND THEIR USE IN CANCER THERAPY Auckland Uniservices Limited (NZ) 2011-01-26 EP disclosed
WO-2009120094-A2 SUBSTITUTED PYRIMIDINES AND TRIAZINES AND THEIR USE IN CANCER THERAPY AUCKLAND UNISERVICES LIMITED (NZ) 2009-10-01 WO disclosed